Neovent

Target Countries

Kenya, Nepal

Target SDGs

Market Suggested Retail Price

$100.00

Target Users (Target Impact Group)

Community, Small and Medium-sized Enterprises

Distributors / Implementing Organizations

The product is in the clinical trial phase, so there is no distribution as of yet. They plan to do a market launch in 2019. Interview with representative

Manufacturing/Building Method

This product is a prototype. The designers constructed it in Dr. Peter Gustafson’s lab in WMU’s College of Engineering and Applied Sciences.

Intellectural Property Type

Patent Protected

User Provision Model

The product is currently in clinical trials and not yet available for purchase. The projected market launch is planned for 2019. Interview with representative

Distributions to Date Status

20 machines are being tested in Nepal and an additional 2 are in trials in Kenya. Interview with representative

Design Specifications

The Neovent is an infant ventilator which delivers dual level treatment. It does so by collecting bubbles, rising due to buoyancy, venting the bubbles and sinking. This cycle then repeats.

Product Schematics

Technical Support

Technical support is provided by the manufacturer while the product undergoes clinical trials. Interview with representative

Replacement Components

Replacement components are not yet available.

Lifecycle

The Neovent can support 4 patients per device and run continuously for one month.

Manufacturer Specified Performance Parameters

Performance Targets include: - With training, local staff should be able to set up the Neovent in under 2 minutes, 30 seconds - 4 patients per device - 6 PI testing nodes

Vetted Performance Status

The product is currently in clinical trials in Kenya and Nepal.

Safety

Unknown

Complementary Technical Systems

CPAP Setup

Academic Research and References

Compliance with regulations

Unknown

Evaluation methods

The device is undergoing clinical trials.

Other Information

The product is featured as 2018 National iShow winner.